We implement strict full‑process quality control covering raw material incoming inspection, in‑process production monitoring and finished‑product testing.
Our production site is equipped with GMP‑compliant workshops and DCS automatic control system to stabilize batch consistency.
We hold <b>Utility Model Patent (ZL 2023 2 1681296.9)</b> for pharmaceutical intermediate rapid‑grinding manufacturing equipment.
Certificate of Analysis (COA) is available for each batch of fine chemicals, pharmaceutical intermediates and peptide raw materials.
We support CDMO & CRO custom synthesis projects, complying with industry‑standard quality requirements for pharma‑grade raw materials.